Home / Tags / Roche

Roche

Roche Headquarters

Roche announces 2023 sales and earnings decrease

Monday, February 5, 2024

A strong Swiss franc as well as the decline in sales in the coronavirus business and strong competition from generic products have impacted Roche in 2023. In the past financial year, the pharmaceutical company recorded sales growth of one percent at constant exchange rates to CHF 58.7 billion. This increase in sales...

Read more
Roche CEO Dr. Thomas Schinecker

Pharma business of Roche posts solid growth in first half of 2023

Thursday, July 27, 2023

Even though Roche's pharmaceuticals business with prescription medicines continues to grow, the company suffered declining overall sales in the first half of 2023 due to the expected drop in demand for Covid-19 products. Roche Group sales fell eight percent to CHF 29.8 billion. The appreciation of the Swiss franc...

Read more
CEO Severin Schwan expects a low-single-digit decline in Group sales in 2023 due to further declining demand for Covid-19 products

Roche to increase sales slightly to 63.3 billion francs in 2022

Monday, February 6, 2023

Shrinking demand for tests and medicines to treat Covid-19 has left its mark on Roche's annual results. The bottom line saw net income fall six percent to 13.5 billion Swiss francs from 14.9 billion a year earlier. The Swiss pharmaceutical group posted sales of 63.3 billion Swiss francs in 2022. This represents an...

Read more
Roche Headquarter

Roche acquires Stratos Genomics to further develop DNA based sequencing for diagnostic use

Wednesday, May 27, 2020

Roche announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche’s nanopore sequencer. The acquisition provides Roche access to Stratos Genomics unique chemistry, Sequencing by Expansion (SBX). The Roche nanopore sequencer, once developed, will...

Read more
Dr. Aviv Regev

Changes to the Roche Enlarged Corporate Executive Committee

Wednesday, May 13, 2020

Roche announced that Michael Varney (1958) Ph.D., and Head of Genentech Research and Early Development (gRED) since 2015, will retire from the company at the end of July.  Aviv Regev (1971), Ph.D., and currently Chair of the Faculty, Core Institute Member, and member of the Executive Leadership Team of the Broad...

Read more

Surftipps